Global RNA-based Biopharmaceuticals Market Survey and Trend Research 2018
SUMMARY
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 RNA-based Biopharmaceuticals Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 RNA-BASED BIOPHARMACEUTICALS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Roche (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Sanofi-Aventis (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Abbott Laboratories (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Benitec Biopharma (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Benitec Biopharma (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Calimmune Inc (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Dicerna (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Gradalis (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Quark (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 RXi (Company Overview, Sales Data etc.)
4.12 Senesco (Company Overview, Sales Data etc.)
4.13 Silence Therapeutics (Company Overview, Sales Data etc.)
4.14 Silenseed (Company Overview, Sales Data etc.)
4.15 Tekmira (Company Overview, Sales Data etc.)
4.16 Alnylam Pharmaceuticals (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 RNA-based Biopharmaceuticals Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 RNA-BASED BIOPHARMACEUTICALS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Roche (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Sanofi-Aventis (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Abbott Laboratories (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Benitec Biopharma (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Benitec Biopharma (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Calimmune Inc (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Dicerna (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Gradalis (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Quark (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 RXi (Company Overview, Sales Data etc.)
4.12 Senesco (Company Overview, Sales Data etc.)
4.13 Silence Therapeutics (Company Overview, Sales Data etc.)
4.14 Silenseed (Company Overview, Sales Data etc.)
4.15 Tekmira (Company Overview, Sales Data etc.)
4.16 Alnylam Pharmaceuticals (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Type, in USD Million
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Type, in Volume
Table Global RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Type, in USD Million
Table Global RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table RNA-based Biopharmaceuticals Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table RNA-based Biopharmaceuticals Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table RNA-based Biopharmaceuticals Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table RNA-based Biopharmaceuticals Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Benitec Biopharma Overview List
Table RNA-based Biopharmaceuticals Business Operation of Benitec Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Benitec Biopharma Overview List
Table RNA-based Biopharmaceuticals Business Operation of Benitec Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Calimmune Inc Overview List
Table RNA-based Biopharmaceuticals Business Operation of Calimmune Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Overview List
Table RNA-based Biopharmaceuticals Business Operation of Dicerna (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Overview List
Table RNA-based Biopharmaceuticals Business Operation of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Overview List
Table RNA-based Biopharmaceuticals Business Operation of Quark (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Overview List
Table RNA-based Biopharmaceuticals Business Operation of RXi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Senesco Overview List
Table RNA-based Biopharmaceuticals Business Operation of Senesco (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Silence Therapeutics Overview List
Table RNA-based Biopharmaceuticals Business Operation of Silence Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Silenseed Overview List
Table RNA-based Biopharmaceuticals Business Operation of Silenseed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tekmira Overview List
Table RNA-based Biopharmaceuticals Business Operation of Tekmira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alnylam Pharmaceuticals Overview List
Table RNA-based Biopharmaceuticals Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global RNA-based Biopharmaceuticals Sales Revenue 2012-2017, by Companies, in USD Million
Table Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies, in USD Million
Table Global RNA-based Biopharmaceuticals Sales Volume 2012-2017, by Companies, in Volume
Table Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies in 2017, in Volume
Table RNA-based Biopharmaceuticals Demand 2012-2017, by Application, in USD Million
Table RNA-based Biopharmaceuticals Demand 2012-2017, by Application, in Volume
Table RNA-based Biopharmaceuticals Demand Forecast 2018-2023, by Application, in USD Million
Table RNA-based Biopharmaceuticals Demand Forecast 2018-2023, by Application, in Volume
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Region, in USD Million
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Region, in Volume
Table RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Region, in USD Million
Table RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Region, in Volume
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Type, in USD Million
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Type, in Volume
Table Global RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Type, in USD Million
Table Global RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table RNA-based Biopharmaceuticals Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table RNA-based Biopharmaceuticals Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table RNA-based Biopharmaceuticals Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table RNA-based Biopharmaceuticals Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Benitec Biopharma Overview List
Table RNA-based Biopharmaceuticals Business Operation of Benitec Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Benitec Biopharma Overview List
Table RNA-based Biopharmaceuticals Business Operation of Benitec Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Calimmune Inc Overview List
Table RNA-based Biopharmaceuticals Business Operation of Calimmune Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Overview List
Table RNA-based Biopharmaceuticals Business Operation of Dicerna (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Overview List
Table RNA-based Biopharmaceuticals Business Operation of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Overview List
Table RNA-based Biopharmaceuticals Business Operation of Quark (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Overview List
Table RNA-based Biopharmaceuticals Business Operation of RXi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Senesco Overview List
Table RNA-based Biopharmaceuticals Business Operation of Senesco (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Silence Therapeutics Overview List
Table RNA-based Biopharmaceuticals Business Operation of Silence Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Silenseed Overview List
Table RNA-based Biopharmaceuticals Business Operation of Silenseed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tekmira Overview List
Table RNA-based Biopharmaceuticals Business Operation of Tekmira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alnylam Pharmaceuticals Overview List
Table RNA-based Biopharmaceuticals Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global RNA-based Biopharmaceuticals Sales Revenue 2012-2017, by Companies, in USD Million
Table Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies, in USD Million
Table Global RNA-based Biopharmaceuticals Sales Volume 2012-2017, by Companies, in Volume
Table Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies in 2017, in Volume
Table RNA-based Biopharmaceuticals Demand 2012-2017, by Application, in USD Million
Table RNA-based Biopharmaceuticals Demand 2012-2017, by Application, in Volume
Table RNA-based Biopharmaceuticals Demand Forecast 2018-2023, by Application, in USD Million
Table RNA-based Biopharmaceuticals Demand Forecast 2018-2023, by Application, in Volume
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Region, in USD Million
Table Global RNA-based Biopharmaceuticals Market 2012-2017, by Region, in Volume
Table RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Region, in USD Million
Table RNA-based Biopharmaceuticals Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure RNA-based Biopharmaceuticals Industry Chain Structure
Figure Global RNA-based Biopharmaceuticals Market Growth 2012-2017, by Type, in USD Million
Figure Global RNA-based Biopharmaceuticals Market Growth 2012-2017, by Type, in Volume
Figure Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global RNA-based Biopharmaceuticals Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure RNA-based Biopharmaceuticals Industry Chain Structure
Figure Global RNA-based Biopharmaceuticals Market Growth 2012-2017, by Type, in USD Million
Figure Global RNA-based Biopharmaceuticals Market Growth 2012-2017, by Type, in Volume
Figure Global RNA-based Biopharmaceuticals Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global RNA-based Biopharmaceuticals Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
